Search

Your search keyword '"Niedoszytko, M."' showing total 1,222 results

Search Constraints

Start Over You searched for: "Niedoszytko, M." Remove constraint "Niedoszytko, M."
1,222 results on '"Niedoszytko, M."'

Search Results

1. Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.

2. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

3. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

4. Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.

5. Cardiac adverse drug reactions to COVID-19 vaccines. A cross-sectional study based on the Europe-wide data.

6. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

7. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

8. Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air ® .

9. The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.

10. The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing.

11. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.

12. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study.

13. Analysis of Allergy and Hypersensitivity Reactions to COVID-19 Vaccines According to the EudraVigilance Database.

14. Venom Immunotherapy Does Not Affect Survival of Patients with Malignant Tumor in Poland.

16. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

18. Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

19. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

20. Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis.

21. The ARIA-MeDALL hypothesis

22. Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study.

23. Basophil Activation Test Is Inferior to Provocation Test in Diagnosing Aspirin Hypersensitivity.

24. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

25. Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study.

26. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.

27. The usability of testing skin reaction applying skin prick tests with Comirnaty (Pfizer, USA) vaccine in detecting the risk of developing post-vaccination immediate hypersensitivity response (anaphylaxis) after administration of this vaccine.

28. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

29. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

30. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

31. Clinical Application of In Vitro Tests for COVID-19 Vaccine Delayed Hypersensitivity Diagnostics.

32. Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study.

33. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.

34. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

35. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.

36. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.

37. Cutoff Values of MASK-air Patient-Reported Outcome Measures.

38. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study.

39. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study.

40. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

41. Management of anaphylaxis due to COVID-19 vaccines in the elderly

43. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

44. COMMD8 changes expression during initial phase of wasp venom immunotherapy.

45. Conut score as a tool for early detection of poor nutritional status in advances forms of SM

46. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

47. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

48. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

49. YKL-40 as a possible marker of neutrophilic asthma.

50. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.

Catalog

Books, media, physical & digital resources